LeonaBio Inc LONA Q1 2026 Earnings EPS Surprise Provides Bright Spot Amid Revenue Absence and Stock Decline ADPT Q1 2026 Earnings EPS Beat Driven by Cost Discipline and Operational Progress AMAL Q1 2026 Earnings EPS Falls Short of Estimates Revenue Not Disclosed PCG Q1 2026 Earnings EPS Beats Estimates by 187 as Utility Navigates Regulatory Landscape LSAK Q1 2026 Earnings Massive EPS Beat Signals Strong Profitability Surge REKR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Drops